cetuximab,afatinib,pembrolizumab,adagrasib
mirati,boehringer ingelheim,eli lilly,merck
['cetuximab', 'krystal-1', 'kudos', 'adagrasib']
#esmo22 krystal-1 update adagrasib + cetuximab with a dcr of 100% and a orr: 46% this may not be a chalabi plot so, that s what we re calling it now! excellent work! kudos to 
Maria Cecília Mathias - Medical Oncologist and GI Fellow @grupoOncoclínicas ?? Former Oncology Fellow @ ICESP  | ?? Baiana ??????and proud of it! ????